High-dose octreotide acetate for management of gastroenteropancreatic neuroendocrine tumors. [electronic resource]
- Anticancer research Oct 2009
- 4127-30 p. digital
Publication Type: Journal Article
1791-7530
Adult Aged Aged, 80 and over Antineoplastic Agents, Hormonal--administration & dosage Dose-Response Relationship, Drug Female Gastrointestinal Neoplasms--drug therapy Humans Male Middle Aged Neuroendocrine Tumors--drug therapy Octreotide--administration & dosage Retrospective Studies